Brief: Mink Therapeutics' Agent-797 Shows Promising Results In The Treatment Of Severe Acute Respiratory Distress
06/02/2024 14:42
Feb 6 (Reuters) - Mink Therapeutics Inc INKT.O :
* MINK THERAPEUTICS' AGENT-797 SHOWS PROMISING RESULTS IN
THE
TREATMENT OF SEVERE ACUTE RESPIRATORY DISTRESS, PUBLISHED IN
NATURE COMMUNICATIONS
Source text for Eikon: ID:nGNX4MpZwj
Further company coverage: INKT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mink Therapeutics
See all newsMiNK Therapeutics Q2 loss narrows on expense discipline
Brief: MiNK Therapeutics Q2 EPS USD -0.62
Mink Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: MiNK Therapeutics Says No Major Serious Adverse Events Attributed To Agent-797 In First Patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's